Lyon, France - January 20, 2026, 18:00 p.m. CET - THX Pharma (Theranexus), an innovative biopharmaceutical company in the treatment of rare neurological diseases, today announces its financial communi ...
The Board of Directors of THX Pharma (Theranexus), a pharmaceutical company specializing in rare neurological diseases, today announces the appointment of Julien Veys as Deputy Chief Executive Officer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback